Details for Patent: 5,656,667
✉ Email this page to a colleague
Summary for Patent: 5,656,667
| Title: | Fatty acid composition |
| Abstract: | Fatty acid composition comprising at least 80% by weight of omega-3-fatty acids, salts or derivatives thereof, wherein (all-Z)-5,8,11,14,17-eicosapentaenoic acid (EPA) and (all-Z)-4,7,10,13,16,19-docosahexaenoic acid comprises at least 75% by weight of the total fatty acids. The compositions can be used for the treatment or prophylaxis of multiple risk factors for cardiovascular diseases. |
| Inventor(s): | Harald Breivik, Bernt B.o slashed.rretzen, Knut Helkås Dahl, Hans Einar Krokan, Kaare Harald B.o slashed.naa |
| Assignee: | Pronova Biopharma Norge AS |
| Application Number: | US08/471,200 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; Dosage form; |
Drugs Protected by US Patent 5,656,667
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,656,667
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 398779 | ⤷ Start Trial | |||
| Austria | A191889 | ⤷ Start Trial | |||
| Australia | 3896789 | ⤷ Start Trial | |||
| Australia | 616784 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
